0 NASDAQ Companies - March 4, 2019ChemoCentryx to Hold Fourth Quarter 2018 Financial Results Conference Call on Monday, March 11, 2019Read More
0 NASDAQ Companies - March 4, 2019Vericel to Present at Multiple Upcoming Investor ConferencesRead More
0 NASDAQ Companies - March 4, 2019Lantronix to Unveil New ConsoleFlow™ Software Release at Cisco Live AustraliaRead More
0 NASDAQ Companies - March 4, 2019Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDARead More
0 NASDAQ Companies - March 4, 2019ITC Institutes Section 337 Investigation Based on Align Technology Claims of Scanner Related 3Shape Patent InfringementRead More
0 NASDAQ Companies - March 4, 2019BioTelemetry, Inc. Completes Acquisition of Geneva Healthcare, Inc.Read More
0 NASDAQ Companies - March 4, 2019Capstone Realizes Opportunities in the Expanding California Cannabis Industry with Consecutive Orders for Two Grow FacilitiesRead More
0 NASDAQ Companies - March 4, 2019SELLAS Life Sciences Announces Presentation of Final Data Analysis from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2019 ASCO-SITC Clinical Immuno-Oncology MeetingRead More
0 NASDAQ Companies - March 4, 2019PhaseBio Appoints Richard A. van den Broek to Board of DirectorsRead More
0 NASDAQ Companies - March 4, 2019Celsion Announces GEN-1 Data Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumRead More
